A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 41
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : IC
Long Form : intracavernous
No. Year Title Co-occurring Abbreviation
2019 Mesenchymal stem cell-derived exosomes ameliorate erection by reducing oxidative stress damage of corpus cavernosum in a rat model of artery injury. ED, MSC-Exos, MSCs
2019 Safety and Efficacy of Intracavernosal Injections of AbobotulinumtoxinA (Dysport) as Add on Therapy to Phosphosdiesterase Type 5 Inhibitors or Prostaglandin E1 for Erectile Dysfunction-Case Studies. ED, PDE5-Is
2018 MSC-derived exosomes ameliorate erectile dysfunction by alleviation of corpus cavernosum smooth muscle apoptosis in a rat model of cavernous nerve injury. CCSMCs, CNI, MSC-Exos, SD
2017 Delivery of intracavernosal therapies using needle-free injection devices. ICI, NFI
2017 Therapeutic effects of adipose-derived stem cells-based microtissues on erectile dysfunction in streptozotocin-induced diabetic rats. ADSCs, CC, ED, ICP, MTs, NGF, nNOS, PBS, STZ, TSG-6, VEGF
2016 Effects of adipose-derived stem cells plus insulin on erectile function in streptozotocin-induced diabetic rats. ADSCs, DM, ED, LIX, PBS, STZ, TIMP1
2015 Adipose-derived stem cells ameliorate erectile dysfunction after cavernous nerve cryoinjury. ADSC, CN
2015 Novel therapeutic approach for neurogenic erectile dysfunction: effect of neurotrophic tyrosine kinase receptor type 1 monoclonal antibody. CNI, ED, IgG, IMPG, PBS, WB
2014 Intracavernous delivery of clonal mesenchymal stem cells restores erectile function in a mouse model of cavernous nerve injury. BMSCs, CNI, ED, i.p, SCM
10  2014 Therapeutic potential of adipose-derived stem cells-based micro-tissues in a rat model of postprostatectomy erectile dysfunction. ADSCs, CC, CNs, ED, EdU, MTs, PBS, SCs, SD
11  2013 Stem-cell therapy for erectile dysfunction. ED, SCs
12  2013 The selective Rho-kinase inhibitor azaindole-1 has long-lasting erectile activity in the rat. AUC, ICP, MAP, ROCK, sGC
13  2012 Recruitment of intracavernously injected adipose-derived stem cells to the major pelvic ganglion improves erectile function in a rat model of cavernous nerve injury. ADSC, CN, ED, EdU, MPG, SDF-1
14  2012 Stem cell therapy for erectile dysfunction: a critical review. CN, ED, SC
15  2011 Experience with intracavernous injection in the treatment of erectile dysfunction after radical prostatectomy: dose considerations. NS
16  2011 Tracking intracavernously injected adipose-derived stem cells to bone marrow. ADSCs, CN, ED, EdU, PSMCs, SCs
17  2010 Intracavernosal administration of sodium nitrite as an erectile pharmacotherapy. L-NAME, NO, NOS
18  2009 Statistical evaluation of hemodynamic effects of regular use of sildenafil on the human corpora cavernosa. ED
19  2004 Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy. IIEF, PGE1, SHIM, SHIM
20  2002 Efficacy of vardenafil and sildenafil in facilitating penile erection in an animal model. i.v, ICP, PDE-5, PNS, SAP
21  2002 Enhancement of apomorphine-induced penile erection in the rat by a selective alpha(1D)-adrenoceptor antagonist. CC, i.p, NA
22  2002 Intracavernous administration of SIN-1+VIP in an in vivo rabbit model for erectile function. max. ICP, NO, NOS, VIP
23  2002 Intracavernous application of diazepam: an alternative route of the seizure treatment--an experimental study in rabbits. DZ, i.v
24  2002 The use of the corpus cavernosum for the administration of phenobarbital: an experimental study in dogs. PB, SE
25  2002 [Methylene blue: an effective therapeutic alternative for priapism induced by intracavernous injection of vasoactive agents]. CCIT, MB
26  2001 Methylene blue as a successful treatment alternative for pharmacologically induced priapism. CCIT, MB
27  2000 Effects of intracavernous administration of selective antagonists of alpha(1)-adrenoceptor subtypes on erection in anesthetized rats and dogs. BP, ICP
28  1999 Maximisation of the erectile response in the investigation of impotence. ICI
29  1997 Functional and radiologic evidence of vascular communication between the spongiosal and cavernosal compartments of the penis. ICP
30  1997 Pharmacodynamics of intracavernously injected drugs and cavernous wall resistance. ---
31  1996 Concurrent elicitation of electroencephalographic desynchronization and penile erection by cocaine in the rat. EEG, i.v
32  1996 Multifactorial evaluation of diabetic erectile dysfunction. CCE, DIC, VOD
33  1996 Nitric oxide as a mediator of cocaine-induced penile erection in the rat. ICP
34  1996 Pharmacokinetics of moxisylyte in healthy volunteers after intracavernous injection of increasing doses. DAM, MDAM
35  1996 Pharmacokinetics of moxisylyte in healthy volunteers after intravenous infusion and intracavernous administration with and without a penile tourniquet. DAM, i.v, MDAM
36  1993 Pharmacokinetics of moxisylyte in healthy volunteers after intravenous and intracavernous administration. DAM, MDAM
37  1992 Diagnosis of venous leakage by 133Xe corporeal clearance after intracavernous injection of prostaglandin E1 in poorly responding patients. PGE-1, ROI, VL
38  1992 [Transdermal therapy of erectile insufficiency]. TS, YOH
39  1989 [Diagnostic and therapeutic applications of intracavernous injection of vasoactive drugs in impotence. Defense for the use of facilitating drugs. Part I--Pharmacology, classification and complications of active drugs]. ---
40  1988 [Metaraminol in therapy of various forms of priapism]. ---
41  1987 Penile pharmacocavernosography and cavernosometry in the evaluation of impotence. PCG, PCM